A DOUBLE-BLINDED RANDOMIZED CONTROL STUDY TO COMPARETHEEFFECTIVENESS AND SAFETY OF INTRALESIONAL VITAMIN D3 WITHINTRALESIONAL TRIAMCINOLONE AND ITâ??S CORRELATION WITH TISSUEEXPRESSION OF VITAMIN D RECEPTORS IN PATIENTS WITH KELOID

DEPARTMENT OF DERMATOLOGY PGIMER CHANDIGARH0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•1. Patient with single keloid or multiple (upper limit 5) of more than 6-month duration. Every keloid selected for study is considered a different entity.
•2. Keloids of size <10cm2 .
•3. The patient who can give valid consent.

•1. Patient with any previous interventional treatment for the same keloid in the 6 months preceding enrollment
•2. Pregnant or lactating females or women who are planning a pregnancy
•3. Keloids on the face
•4. Immunosuppressed patients
•5. Patient with chronic inflammatory diseases; patients with a history of renal or liver failure
•6.Patients with a history of hypersensitivity to any of the study drugs
•7. Patients with a history of non-responsiveness to any of the treatment modalities
•8. The patient who is not willing to provide consent for the study.
•9. Patient with active inflammation, infection, or ulcer in and around the keloid

发起方

DEPARTMENT OF DERMATOLOGY PGIMER CHANDIGARH